Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson pledges $600,000 in disaster relief in response to the bushfire crisis in Australia
Croajingolong National Park, which has been affected by the Australia bushfires

Johnson & Johnson pledges $600,000 in disaster relief in response to the bushfire crisis in Australia

It’s just one way the company has mobilized to help the country with both emergency and recovery efforts in the wake of the large-scale fires.

Like many across the world, Johnson & Johnson has been deeply moved by the scale of the devastating bushfires that have swept Australia.

In response to the crisis, which began in September of last year, the Johnson & Johnson Family of Companies ANZ initially contributed $50,000 to the Australian Red Cross Disaster Fund in November. Since then, as the enormity of the disaster has dramatically increased, the organization has been in contact with its disaster relief partners to determine how best to further support their work, both now and during the recovery process.

We will continue to do all we can to support the affected communities now and in the coming months.
Sue Martin

To help do this, Johnson & Johnson is donating a total of $600,000 in financial support to the Australian Red Cross and St Vincent de Paul Society to aid people in the afflicted areas, as well as donating 200,000 units of personal care items in addition to its ongoing product donation program through Foodbank, an organization that helps fight hunger in Australia. The company is also providing uncapped paid leave for employees who are volunteering with emergency services working to combat the fires and their destruction.

Johnson & Johnson’s thoughts are with those directly affected by these fires, as well as the brave firefighters, community groups involved in disaster relief efforts and all those volunteering in their communities.

“I’m proud to work at a company with a long history of providing assistance during disasters and an ongoing commitment to supporting the communities in which we live and work,” says Sue Martin, Managing Director, Australia & New Zealand, Johnson & Johnson Medical. “We will continue to do all we can to support the affected communities now and in the coming months.”

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.